Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Nyse  >  Teva Pharma Ind.       

TEVA PHARMA IND.
Mes dernières consult.
Most popular
  Report  
SummaryChartsNewsCalendarCompanyFinancialsConsensusRevisions 
 News SummaryMost relevantAll newsSector newsTweets
Most relevant news about TEVA PHARMA IND.
02/16BERKSHIRE HATHAWAY : Cramer shocked by Buffett's investment in "second-rate" Tev..
AQ
02/16Backstory - Warren Buffett's Valentine's Day surprise for investors
RE
02/16WARREN BUFFETT : Warren Buffett's Valentine's Day surprise for investors
RE
02/16BACKSTORY : Warren Buffett's Valentine's Day surprise for investors
RE
02/15Cisco Systems and Teva jump while NetApp slumps
AQ
02/15TEVA PHARMACEUTICAL INDUSTRIES : closing Netanya plant, laying off 220
AQ
02/15Teva Spikes on Berkshire Stake
AQ
02/15Teva jumps on Berkshire Hathaway investment
AQ
02/14TEVA PHARMACEUTICAL INDUSTRIES : Announces U.S. Launch of QVAR RediHaler Inhalat..
AQ
02/13TEVA PHARMACEUTICAL INDUSTRIES : Announces Launch of a Generic Version of Syprin..
AQ
02/13Novartis gains U.S. approval for delayed MS drug
RE
02/12TEVA PHARMACEUTICAL INDUSTRIES : Announces U.S. Launch of QVAR® RediHaler™..
BU
02/09MADRIGAL PHARMACEUTICALS : Here’s What’s Moving Teva Pharmaceutical ..
AQ
02/09TEVA PHARMACEUTICAL INDUSTRIES : Announces Launch of a Generic Version of Syprin..
BU
02/09Teva falls on Celltrion warning letter, guidance
AQ
More most relevant news
All news about TEVA PHARMA IND.
02/16BERKSHIRE HATHAWAY : Cramer shocked by Buffett's investment in "second-rate" Tev..
AQ
02/16NOVARTIS : FDA Approves Another New Generic Form of 40mg Copaxone
AQ
02/16Backstory - Warren Buffett's Valentine's Day surprise for investors
RE
02/16WARREN BUFFETT : Warren Buffett's Valentine's Day surprise for investors
RE
02/16BACKSTORY : Warren Buffett's Valentine's Day surprise for investors
RE
02/15Cisco Systems and Teva jump while NetApp slumps
AQ
02/15TEVA PHARMACEUTICAL INDUSTRIES : closing Netanya plant, laying off 220
AQ
02/15TEVA PHARMACEUTICAL INDUSTRIES : Reports 2017 Full Year and Fourth Quarter Finan..
AQ
02/15Teva Spikes on Berkshire Stake
AQ
02/15Teva jumps on Berkshire Hathaway investment
AQ
More news
Sector news : Pharmaceuticals - NEC
02/16S&P 500 caps off strongest week in five years
RE
02/16ASTRAZENECA : U.S. FDA approves AstraZeneca's immunotherapy for lung cancer
RE
02/16NOVARTIS : readies to auction U.S. generic pills business - sources
RE
02/16Pot Pharm - Booming Canada weed sector plots next-wave medicines
RE
02/16POT PHARM : Booming Canada weed sector plots next-wave medicines
RE
02/15ROCHE : to buy Flatiron Health for $1.9 billion to expand cancer care portfolio
RE
More sector news : Pharmaceuticals - NEC
Financials ($)
Sales 2018 19 600 M
EBIT 2018 -
Net income 2018 -
Debt 2018 -
Yield 2018 -
P/E ratio 2018 -
P/E ratio 2019
Capi. / Sales 2018 1,09x
Capi. / Sales 2019 1,10x
Capitalization 21 403 M
Chart TEVA PHARMA IND.
Duration : Period :
Teva Pharma Ind. Technical Analysis Chart | 4-Traders
Income Statement Evolution
Consensus
 
Mean consensus OUTPERFORM
Number of Analysts 2
Average target price 18,5 $
Spread / Average Target -12%
Managers
NameTitle
Kåre Schultz President, Chief Executive Officer & Director
Sol J. Barer Chairman
Carlo de Notaristefani President & CEO-Global Operations
Michael McClellan Chief Financial Officer & Executive Vice President
Amir Elstein Independent Director
Sector and Competitors
1st jan.Capitalization (M$)
TEVA PHARMA IND.0.00%21 403
JOHNSON & JOHNSON-7.19%352 552
NOVARTIS-3.37%224 301
PFIZER-2.84%212 857
ROCHE HOLDING LTD.-9.37%210 327
MERCK AND COMPANY-0.50%149 572